Magnesium gluconate and Lung disorder - a phase IV clinical study of FDA data

Summary:

Lung disorder is found among people who take Magnesium gluconate, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Magnesium gluconate and have Lung disorder. It is created by eHealthMe based on reports of 1,809 people who have side effects when taking Magnesium gluconate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 24, 2023

1,809 people reported to have side effects when taking Magnesium gluconate.
Among them, 6 people (0.33%) have Lung disorder.

What is Magnesium gluconate?

Magnesium gluconate has active ingredients of magnesium. eHealthMe is studying from 1,835 Magnesium gluconate users for its effectiveness, alternative drugs and more.

What is Lung disorder?

Lung disorder (lung disease) is found to be associated with 2,163 drugs and 1,700 conditions by eHealthMe.

Number of Magnesium gluconate and Lung disorder reports submitted per year:

Could Magnesium gluconate cause Lung disorder?

Gender of people who have Lung disorder when taking Magnesium gluconate *:

female: 83.33 %
male: 16.67 %

Age of people who have Lung disorder when taking Magnesium gluconate *:

Common drugs people take besides Magnesium gluconate *:

Common side effects people have besides Lung disorder *:

Breathing Difficulty: 4 people, 66.67%
Head Injury: 4 people, 66.67%
Memory Loss: 4 people, 66.67%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 66.67%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 3 people, 50.00%
Pneumonia: 3 people, 50.00%
Fall: 3 people, 50.00%
Pulmonary Thrombosis (scarring in the lungs): 3 people, 50.00%
Consciousness - Decreased: 3 people, 50.00%
Muscle Function Loss: 3 people, 50.00%

Common conditions people have *:

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 50.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 50.00%
Asthma: 3 people, 50.00%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 2 people, 33.33%
Quit Smoking: 1 person, 16.67%
Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 16.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium gluconate and have Lung disorder?

Check whether Lung disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Magnesium gluconate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lung disorder treatments and more:

Lung disorder (57,188 reports)

COVID vaccines that are related to Lung disorder:

Common drugs associated with Lung disorder:

All the drugs that are associated with Lung disorder:

Lung disorder (2,163 drugs)

Common conditions associated with Lung disorder:

Rheumatoid arthritis: 5,667 reports
Asthma: 2,587 reports
High blood pressure: 2,230 reports
Primary pulmonary hypertension: 1,653 reports

All the conditions that are associated with Lung disorder:

Lung disorder (1,700 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on magnesium (the active ingredients of Magnesium gluconate) and Magnesium gluconate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.